Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1

Justin D. Lu, Milica Milakovic, Alex G. Ortega-Loayza, Angelo V. Marzano, Afsaneh Alavi

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1'. Together they form a unique fingerprint.

Medicine & Life Sciences